Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (571-580 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|May 8, 2019
Solriamfetol: First Global ApprovalAnthony Markham
Drugs|July 23, 2018
Correction to: Andexanet Alfa: First Global ApprovalYoung-A Heo
Drugs|June 27, 2018
Anlotinib: First Global ApprovalYahiya Y Syed
Drugs|June 27, 2018
Regorafenib: A Review in Metastatic Colorectal CancerSohita Dhillon
Drugs|June 28, 2018
Empagliflozin: A Review in Type 2 DiabetesJames E Frampton
Drugs|August 9, 2018
Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal VaccineAnnette Fox, Kylie M Quinn, Kanta Subbarao
Drugs|May 12, 2017
Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel SyndromeGillian M Keating
Drugs|May 12, 2017
Immunotherapy in Urothelial Cancer: Recent Results and Future PerspectivesMatthew S Farina, Kevin T Lundgren, Joaquim Bellmunt
Drugs|May 25, 2017
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed NeonatesErin Kelty, Gary Hulse
Drugs|May 20, 2017
Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future ProspectsMathurin Flamant, Josselin Rigaill, Stephane Paul, et al.
Pageof 708

Showing results (571-580 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|May 8, 2019
Solriamfetol: First Global ApprovalAnthony Markham
Drugs|July 23, 2018
Correction to: Andexanet Alfa: First Global ApprovalYoung-A Heo
Drugs|June 27, 2018
Anlotinib: First Global ApprovalYahiya Y Syed
Drugs|June 27, 2018
Regorafenib: A Review in Metastatic Colorectal CancerSohita Dhillon
Drugs|June 28, 2018
Empagliflozin: A Review in Type 2 DiabetesJames E Frampton
Drugs|August 9, 2018
Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal VaccineAnnette Fox, Kylie M Quinn, Kanta Subbarao
Drugs|May 12, 2017
Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel SyndromeGillian M Keating
Drugs|May 12, 2017
Immunotherapy in Urothelial Cancer: Recent Results and Future PerspectivesMatthew S Farina, Kevin T Lundgren, Joaquim Bellmunt
Drugs|May 25, 2017
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed NeonatesErin Kelty, Gary Hulse
Drugs|May 20, 2017
Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future ProspectsMathurin Flamant, Josselin Rigaill, Stephane Paul, et al.
Pageof 708